{"entity":{"type":"insider","cik":"0001754122","url":"/insider/0001754122","json_url":"/insider/0001754122.json","name":"Knappertz Volker","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":20,"n_filings":15,"first":"2019-02-28","last":"2024-02-29","span_basis":"filed_date"},"name_variants":[{"name":"Knappertz Volker","source":"filing","n_filings":15,"first_seen":"2019-02-28","last_seen":"2024-02-29"}],"transactions":[{"id":3186195,"accession":"0001600620-24-000028","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001600620-24-000028","line_url":"/filing/0001600620-24-000028#line-1","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001754122","owner_name":"Knappertz Volker","owner_url":"/insider/0001754122","role":"Officer (EVP, Research and Development)","officer_title":"EVP, Research and Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4930.0,"shares_display":"4,930","price_per_share":6.1,"price_display":"6.10","price_state":"stated","total_value":30073.0,"total_display":"30,073.00","shares_owned_after":319128.0,"shares_owned_after_display":"319,128","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-27","filed_date":"2024-02-29","scope":"insider"},{"id":2403886,"accession":"0001600620-24-000022","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001600620-24-000022","line_url":"/filing/0001600620-24-000022#line-1","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001754122","owner_name":"Knappertz Volker","owner_url":"/insider/0001754122","role":"Officer (EVP, Research and Development)","officer_title":"EVP, Research and Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25146.0,"shares_display":"25,146","price_per_share":5.48,"price_display":"5.48","price_state":"stated","total_value":137800.08,"total_display":"137,800.08","shares_owned_after":324058.0,"shares_owned_after_display":"324,058","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-20","filed_date":"2024-02-22","scope":"insider"},{"id":4920903,"accession":"0000899243-21-014010","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-014010","line_url":"/filing/0000899243-21-014010#line-1","is_derivative":false,"issuer_cik":"0001351288","issuer_name":"GW PHARMACEUTICALS PLC","issuer_ticker":"GWPH","issuer_name_source":null,"issuer_url":"/issuer/0001351288","owner_cik":"0001754122","owner_name":"Knappertz Volker","owner_url":"/insider/0001754122","role":"Director","officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3060.0,"shares_display":"3,060","price_per_share":18.1,"price_display":"18.10","price_state":"stated","total_value":55386.0,"total_display":"55,386.00","shares_owned_after":92412.0,"shares_owned_after_display":"92,412","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-26","filed_date":"2021-03-30","scope":"insider"},{"id":5486884,"accession":"0000899243-21-002560","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-002560","line_url":"/filing/0000899243-21-002560#line-1","is_derivative":false,"issuer_cik":"0001351288","issuer_name":"GW PHARMACEUTICALS PLC","issuer_ticker":"GWPH","issuer_name_source":null,"issuer_url":"/issuer/0001351288","owner_cik":"0001754122","owner_name":"Knappertz Volker","owner_url":"/insider/0001754122","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":11.67,"price_display":"11.67","price_state":"stated","total_value":70020.0,"total_display":"70,020.00","shares_owned_after":17940.0,"shares_owned_after_display":"17,940","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-19","filed_date":"2021-01-20","scope":"insider"},{"id":2791198,"accession":"0000899243-20-032225","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-032225","line_url":"/filing/0000899243-20-032225#line-1","is_derivative":false,"issuer_cik":"0001351288","issuer_name":"GW PHARMACEUTICALS PLC","issuer_ticker":"GWPH","issuer_name_source":null,"issuer_url":"/issuer/0001351288","owner_cik":"0001754122","owner_name":"Knappertz Volker","owner_url":"/insider/0001754122","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":10.5,"price_display":"10.50","price_state":"stated","total_value":126000.0,"total_display":"126,000.00","shares_owned_after":23940.0,"shares_owned_after_display":"23,940","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-24","filed_date":"2020-11-25","scope":"insider"},{"id":2953896,"accession":"0000899243-20-031062","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-031062","line_url":"/filing/0000899243-20-031062#line-1","is_derivative":false,"issuer_cik":"0001351288","issuer_name":"GW PHARMACEUTICALS PLC","issuer_ticker":"GWPH","issuer_name_source":null,"issuer_url":"/issuer/0001351288","owner_cik":"0001754122","owner_name":"Knappertz Volker","owner_url":"/insider/0001754122","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":60000.0,"total_display":"60,000.00","shares_owned_after":35940.0,"shares_owned_after_display":"35,940","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-11","filed_date":"2020-11-13","scope":"insider"},{"id":2419311,"accession":"0000899243-20-030504","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-030504","line_url":"/filing/0000899243-20-030504#line-1","is_derivative":false,"issuer_cik":"0001351288","issuer_name":"GW PHARMACEUTICALS PLC","issuer_ticker":"GWPH","issuer_name_source":null,"issuer_url":"/issuer/0001351288","owner_cik":"0001754122","owner_name":"Knappertz Volker","owner_url":"/insider/0001754122","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":9.17,"price_display":"9.17","price_state":"stated","total_value":55020.0,"total_display":"55,020.00","shares_owned_after":41940.0,"shares_owned_after_display":"41,940","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-04","filed_date":"2020-11-05","scope":"insider"},{"id":2248673,"accession":"0000899243-20-021685","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-021685","line_url":"/filing/0000899243-20-021685#line-1","is_derivative":false,"issuer_cik":"0001351288","issuer_name":"GW PHARMACEUTICALS PLC","issuer_ticker":"GWPH","issuer_name_source":null,"issuer_url":"/issuer/0001351288","owner_cik":"0001754122","owner_name":"Knappertz Volker","owner_url":"/insider/0001754122","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":11.11,"price_display":"11.11","price_state":"stated","total_value":66660.0,"total_display":"66,660.00","shares_owned_after":47940.0,"shares_owned_after_display":"47,940","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-04","filed_date":"2020-08-06","scope":"insider"},{"id":3279902,"accession":"0000899243-20-020102","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-020102","line_url":"/filing/0000899243-20-020102#line-1","is_derivative":false,"issuer_cik":"0001351288","issuer_name":"GW PHARMACEUTICALS PLC","issuer_ticker":"GWPH","issuer_name_source":null,"issuer_url":"/issuer/0001351288","owner_cik":"0001754122","owner_name":"Knappertz Volker","owner_url":"/insider/0001754122","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":11.42,"price_display":"11.42","price_state":"stated","total_value":68520.0,"total_display":"68,520.00","shares_owned_after":53940.0,"shares_owned_after_display":"53,940","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-20","filed_date":"2020-07-22","scope":"insider"},{"id":3239200,"accession":"0000899243-20-017299","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-017299","line_url":"/filing/0000899243-20-017299#line-2","is_derivative":false,"issuer_cik":"0001351288","issuer_name":"GW PHARMACEUTICALS PLC","issuer_ticker":"GWPH","issuer_name_source":null,"issuer_url":"/issuer/0001351288","owner_cik":"0001754122","owner_name":"Knappertz Volker","owner_url":"/insider/0001754122","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18000.0,"shares_display":"18,000","price_per_share":10.35,"price_display":"10.35","price_state":"stated","total_value":186300.0,"total_display":"186,300.00","shares_owned_after":59940.0,"shares_owned_after_display":"59,940","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-17","filed_date":"2020-06-19","scope":"insider"},{"id":2375418,"accession":"0000899243-20-006993","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-006993","line_url":"/filing/0000899243-20-006993#line-1","is_derivative":false,"issuer_cik":"0001351288","issuer_name":"GW PHARMACEUTICALS PLC","issuer_ticker":"GWPH","issuer_name_source":null,"issuer_url":"/issuer/0001351288","owner_cik":"0001754122","owner_name":"Knappertz Volker","owner_url":"/insider/0001754122","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3420.0,"shares_display":"3,420","price_per_share":8.32,"price_display":"8.32","price_state":"stated","total_value":28454.4,"total_display":"28,454.40","shares_owned_after":79392.0,"shares_owned_after_display":"79,392","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-02","filed_date":"2020-03-04","scope":"insider"},{"id":2375407,"accession":"0000899243-20-006329","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-006329","line_url":"/filing/0000899243-20-006329#line-2","is_derivative":false,"issuer_cik":"0001351288","issuer_name":"GW PHARMACEUTICALS PLC","issuer_ticker":"GWPH","issuer_name_source":null,"issuer_url":"/issuer/0001351288","owner_cik":"0001754122","owner_name":"Knappertz Volker","owner_url":"/insider/0001754122","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2832.0,"shares_display":"2,832","price_per_share":9.17,"price_display":"9.17","price_state":"stated","total_value":25969.44,"total_display":"25,969.44","shares_owned_after":82992.0,"shares_owned_after_display":"82,992","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-26","filed_date":"2020-02-28","scope":"insider"},{"id":2375403,"accession":"0000899243-20-006329","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-006329","line_url":"/filing/0000899243-20-006329#line-1","is_derivative":false,"issuer_cik":"0001351288","issuer_name":"GW PHARMACEUTICALS PLC","issuer_ticker":"GWPH","issuer_name_source":null,"issuer_url":"/issuer/0001351288","owner_cik":"0001754122","owner_name":"Knappertz Volker","owner_url":"/insider/0001754122","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":180.0,"shares_display":"180","price_per_share":9.26,"price_display":"9.26","price_state":"stated","total_value":1666.8,"total_display":"1,666.80","shares_owned_after":82812.0,"shares_owned_after_display":"82,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-26","filed_date":"2020-02-28","scope":"insider"},{"id":8022124,"accession":"0000899243-19-014292","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-19-014292","line_url":"/filing/0000899243-19-014292#line-3","is_derivative":false,"issuer_cik":"0001351288","issuer_name":"GW PHARMACEUTICALS PLC","issuer_ticker":"GWPH","issuer_name_source":null,"issuer_url":"/issuer/0001351288","owner_cik":"0001754122","owner_name":"Knappertz Volker","owner_url":"/insider/0001754122","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6312.0,"shares_display":"6,312","price_per_share":14.76,"price_display":"14.76","price_state":"stated","total_value":93165.12,"total_display":"93,165.12","shares_owned_after":85824.0,"shares_owned_after_display":"85,824","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-20","filed_date":"2019-05-21","scope":"insider"},{"id":8022122,"accession":"0000899243-19-014292","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-014292","line_url":"/filing/0000899243-19-014292#line-2","is_derivative":false,"issuer_cik":"0001351288","issuer_name":"GW PHARMACEUTICALS PLC","issuer_ticker":"GWPH","issuer_name_source":null,"issuer_url":"/issuer/0001351288","owner_cik":"0001754122","owner_name":"Knappertz Volker","owner_url":"/insider/0001754122","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5832.0,"shares_display":"5,832","price_per_share":14.52,"price_display":"14.52","price_state":"stated","total_value":84680.64,"total_display":"84,680.64","shares_owned_after":92136.0,"shares_owned_after_display":"92,136","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-20","filed_date":"2019-05-21","scope":"insider"},{"id":3239193,"accession":"0000899243-20-017299","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-017299","line_url":"/filing/0000899243-20-017299#line-1","is_derivative":false,"issuer_cik":"0001351288","issuer_name":"GW PHARMACEUTICALS PLC","issuer_ticker":"GWPH","issuer_name_source":null,"issuer_url":"/issuer/0001351288","owner_cik":"0001754122","owner_name":"Knappertz Volker","owner_url":"/insider/0001754122","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4296.0,"shares_display":"4,296","price_per_share":14.63,"price_display":"14.63","price_state":"stated","total_value":62850.48,"total_display":"62,850.48","shares_owned_after":77940.0,"shares_owned_after_display":"77,940","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-15","filed_date":"2020-06-19","scope":"insider"},{"id":7909064,"accession":"0000899243-19-006334","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-006334","line_url":"/filing/0000899243-19-006334#line-1","is_derivative":false,"issuer_cik":"0001351288","issuer_name":"GW PHARMACEUTICALS PLC","issuer_ticker":"GWPH","issuer_name_source":null,"issuer_url":"/issuer/0001351288","owner_cik":"0001754122","owner_name":"Knappertz Volker","owner_url":"/insider/0001754122","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3732.0,"shares_display":"3,732","price_per_share":14.46,"price_display":"14.46","price_state":"stated","total_value":53964.72,"total_display":"53,964.72","shares_owned_after":8736.0,"shares_owned_after_display":"8,736","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-01","filed_date":"2019-03-05","scope":"insider"},{"id":8502477,"accession":"0000899243-19-005262","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-19-005262","line_url":"/filing/0000899243-19-005262#line-4","is_derivative":false,"issuer_cik":"0001351288","issuer_name":"GW PHARMACEUTICALS PLC","issuer_ticker":"GWPH","issuer_name_source":null,"issuer_url":"/issuer/0001351288","owner_cik":"0001754122","owner_name":"Knappertz Volker","owner_url":"/insider/0001754122","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3600.0,"shares_display":"3,600","price_per_share":12.46,"price_display":"12.46","price_state":"stated","total_value":44856.0,"total_display":"44,856.00","shares_owned_after":12504.0,"shares_owned_after_display":"12,504","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-26","filed_date":"2019-02-28","scope":"insider"},{"id":8502472,"accession":"0000899243-19-005262","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-19-005262","line_url":"/filing/0000899243-19-005262#line-3","is_derivative":false,"issuer_cik":"0001351288","issuer_name":"GW PHARMACEUTICALS PLC","issuer_ticker":"GWPH","issuer_name_source":null,"issuer_url":"/issuer/0001351288","owner_cik":"0001754122","owner_name":"Knappertz Volker","owner_url":"/insider/0001754122","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":504.0,"shares_display":"504","price_per_share":12.44,"price_display":"12.44","price_state":"stated","total_value":6269.76,"total_display":"6,269.76","shares_owned_after":16104.0,"shares_owned_after_display":"16,104","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-26","filed_date":"2019-02-28","scope":"insider"},{"id":8502467,"accession":"0000899243-19-005262","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-005262","line_url":"/filing/0000899243-19-005262#line-2","is_derivative":false,"issuer_cik":"0001351288","issuer_name":"GW PHARMACEUTICALS PLC","issuer_ticker":"GWPH","issuer_name_source":null,"issuer_url":"/issuer/0001351288","owner_cik":"0001754122","owner_name":"Knappertz Volker","owner_url":"/insider/0001754122","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36.0,"shares_display":"36","price_per_share":12.29,"price_display":"12.29","price_state":"stated","total_value":442.44,"total_display":"442.44","shares_owned_after":12468.0,"shares_owned_after_display":"12,468","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-26","filed_date":"2019-02-28","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":20,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":20,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":20},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001600620","name":"Aurinia Pharmaceuticals Inc.","url":"/issuer/0001600620","role":"Officer (EVP, Research and Development)","n_filings":2,"first_seen":"2024-02-22","last_seen":"2024-02-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001351288","name":"GW PHARMACEUTICALS PLC","url":"/issuer/0001351288","role":"Director, Officer (Chief Medical Officer)","n_filings":13,"first_seen":"2019-02-28","last_seen":"2021-03-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001754122","retrieved_at":"2026-08-21T05:42:33+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}